Mitchell Shawnte

CHIEF LEGAL OFFICEROlema Pharmaceuticals, Inc. (OLMA) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$952K
Net Open-Market Flow
-$952K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)25K$24.25$601K233
Mar 4, 2026Sell(S)233$24.69$6K0
Mar 4, 2026Option exercise(M)25K$4.37$109K25K
Mar 3, 2026Sell(S)15K$23.01$345K0
Mar 3, 2026Option exercise(M)15K$4.37$66K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)25K$0410K
Mar 3, 2026Option exercise(M)15K$0435K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001749432-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: